FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2895902053> ?p ?o ?g. }

• W2895902053 endingPage "661.e2" @default.
• W2895902053 startingPage "647" @default.
• W2895902053 abstract "Background & AimsIntraductal papillary mucinous neoplasms (IPMNs) are regarded as precursors of pancreatic ductal adenocarcinomas (PDAs), but little is known about the mechanism of progression. This makes it challenging to assess cancer risk in patients with IPMNs. We investigated associations of IPMNs with concurrent PDAs by genetic and histologic analyses.MethodsWe obtained 30 pancreatic tissues with concurrent PDAs and IPMNs, and 168 lesions, including incipient foci, were mapped, microdissected, and analyzed for mutations in 18 pancreatic cancer-associated genes and expression of tumor suppressors.ResultsWe determined the clonal relatedness of lesions, based on driver mutations shared by PDAs and concurrent IPMNs, and classified the lesions into 3 subtypes. Twelve PDAs contained driver mutations shared by all concurrent IPMNs, which we called the sequential subtype. This subset was characterized by less diversity in incipient foci with frequent GNAS mutations. Eleven PDAs contained some driver mutations that were shared with concurrent IPMNs, which we called the branch-off subtype. In this subtype, PDAs and IPMNs had identical KRAS mutations but different GNAS mutations, although the lesions were adjacent. Whole-exome sequencing and methylation analysis of these lesions indicated clonal origin with later divergence. Ten PDAs had driver mutations not found in concurrent IPMNs, called the de novo subtype. Expression profiles of TP53 and SMAD4 increased our ability to differentiate these subtypes compared with sequencing data alone. The branch-off and de novo subtypes had substantial heterogeneity among early clones, such as differences in KRAS mutations. Patients with PDAs of the branch-off subtype had a longer times of disease-free survival than patients with PDAs of the de novo or the sequential subtypes.ConclusionsDetailed histologic and genetic analysis of PDAs and concurrent IPMNs identified 3 different pathways by which IPMNs progress to PDAs—we call these the sequential, branch-off, and de novo subtypes. Subtypes might be associated with clinical and pathologic features and be used to select surveillance programs for patients with IPMNs. Intraductal papillary mucinous neoplasms (IPMNs) are regarded as precursors of pancreatic ductal adenocarcinomas (PDAs), but little is known about the mechanism of progression. This makes it challenging to assess cancer risk in patients with IPMNs. We investigated associations of IPMNs with concurrent PDAs by genetic and histologic analyses. We obtained 30 pancreatic tissues with concurrent PDAs and IPMNs, and 168 lesions, including incipient foci, were mapped, microdissected, and analyzed for mutations in 18 pancreatic cancer-associated genes and expression of tumor suppressors. We determined the clonal relatedness of lesions, based on driver mutations shared by PDAs and concurrent IPMNs, and classified the lesions into 3 subtypes. Twelve PDAs contained driver mutations shared by all concurrent IPMNs, which we called the sequential subtype. This subset was characterized by less diversity in incipient foci with frequent GNAS mutations. Eleven PDAs contained some driver mutations that were shared with concurrent IPMNs, which we called the branch-off subtype. In this subtype, PDAs and IPMNs had identical KRAS mutations but different GNAS mutations, although the lesions were adjacent. Whole-exome sequencing and methylation analysis of these lesions indicated clonal origin with later divergence. Ten PDAs had driver mutations not found in concurrent IPMNs, called the de novo subtype. Expression profiles of TP53 and SMAD4 increased our ability to differentiate these subtypes compared with sequencing data alone. The branch-off and de novo subtypes had substantial heterogeneity among early clones, such as differences in KRAS mutations. Patients with PDAs of the branch-off subtype had a longer times of disease-free survival than patients with PDAs of the de novo or the sequential subtypes. Detailed histologic and genetic analysis of PDAs and concurrent IPMNs identified 3 different pathways by which IPMNs progress to PDAs—we call these the sequential, branch-off, and de novo subtypes. Subtypes might be associated with clinical and pathologic features and be used to select surveillance programs for patients with IPMNs." @default.
• W2895902053 created "2018-10-26" @default.
• W2895902053 creator A5003384004 @default.
• W2895902053 creator A5011882783 @default.
• W2895902053 creator A5012989108 @default.
• W2895902053 creator A5015581986 @default.
• W2895902053 creator A5025471308 @default.
• W2895902053 creator A5025648571 @default.
• W2895902053 creator A5026989956 @default.
• W2895902053 creator A5035197786 @default.
• W2895902053 creator A5038185013 @default.
• W2895902053 creator A5043324219 @default.
• W2895902053 creator A5051565200 @default.
• W2895902053 creator A5051945468 @default.
• W2895902053 creator A5054053950 @default.
• W2895902053 creator A5054072947 @default.
• W2895902053 creator A5056544156 @default.
• W2895902053 creator A5057784648 @default.
• W2895902053 creator A5058692299 @default.
• W2895902053 creator A5069630681 @default.
• W2895902053 creator A5070309718 @default.
• W2895902053 creator A5082418786 @default.
• W2895902053 creator A5086065297 @default.
• W2895902053 date "2019-02-01" @default.
• W2895902053 modified "2023-10-17" @default.
• W2895902053 title "Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular Features" @default.
• W2895902053 cites W1481474198 @default.
• W2895902053 cites W1560020441 @default.
• W2895902053 cites W1580984542 @default.
• W2895902053 cites W1901759064 @default.
• W2895902053 cites W1945428417 @default.
• W2895902053 cites W1969851387 @default.
• W2895902053 cites W1969977977 @default.
• W2895902053 cites W1973950343 @default.
• W2895902053 cites W1975616447 @default.
• W2895902053 cites W1975940378 @default.
• W2895902053 cites W1980447806 @default.
• W2895902053 cites W1987313243 @default.
• W2895902053 cites W1992995822 @default.
• W2895902053 cites W2007570179 @default.
• W2895902053 cites W2010877571 @default.
• W2895902053 cites W2013102168 @default.
• W2895902053 cites W2016383232 @default.
• W2895902053 cites W2016448153 @default.
• W2895902053 cites W2023560061 @default.
• W2895902053 cites W2027624863 @default.
• W2895902053 cites W2043581159 @default.
• W2895902053 cites W2044023070 @default.
• W2895902053 cites W2062696188 @default.
• W2895902053 cites W2067826589 @default.
• W2895902053 cites W2081681778 @default.
• W2895902053 cites W2097935031 @default.
• W2895902053 cites W2114031931 @default.
• W2895902053 cites W2127431419 @default.
• W2895902053 cites W2128198169 @default.
• W2895902053 cites W2129478209 @default.
• W2895902053 cites W2130981598 @default.
• W2895902053 cites W2134145309 @default.
• W2895902053 cites W2150575159 @default.
• W2895902053 cites W2153562609 @default.
• W2895902053 cites W2253146128 @default.
• W2895902053 cites W2284361446 @default.
• W2895902053 cites W2285093314 @default.
• W2895902053 cites W2324090636 @default.
• W2895902053 cites W2344444433 @default.
• W2895902053 cites W2407131726 @default.
• W2895902053 cites W2431396139 @default.
• W2895902053 cites W2473637003 @default.
• W2895902053 cites W2604454943 @default.
• W2895902053 cites W2735984766 @default.
• W2895902053 cites W2736069212 @default.
• W2895902053 cites W2792209856 @default.
• W2895902053 cites W2809279418 @default.
• W2895902053 doi "https://doi.org/10.1053/j.gastro.2018.10.029" @default.
• W2895902053 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30342036" @default.
• W2895902053 hasPublicationYear "2019" @default.
• W2895902053 type Work @default.
• W2895902053 sameAs 2895902053 @default.
• W2895902053 citedByCount "115" @default.
• W2895902053 countsByYear W28959020532019 @default.
• W2895902053 countsByYear W28959020532020 @default.
• W2895902053 countsByYear W28959020532021 @default.
• W2895902053 countsByYear W28959020532022 @default.
• W2895902053 countsByYear W28959020532023 @default.
• W2895902053 crossrefType "journal-article" @default.
• W2895902053 hasAuthorship W2895902053A5003384004 @default.
• W2895902053 hasAuthorship W2895902053A5011882783 @default.
• W2895902053 hasAuthorship W2895902053A5012989108 @default.
• W2895902053 hasAuthorship W2895902053A5015581986 @default.
• W2895902053 hasAuthorship W2895902053A5025471308 @default.
• W2895902053 hasAuthorship W2895902053A5025648571 @default.
• W2895902053 hasAuthorship W2895902053A5026989956 @default.
• W2895902053 hasAuthorship W2895902053A5035197786 @default.
• W2895902053 hasAuthorship W2895902053A5038185013 @default.
• W2895902053 hasAuthorship W2895902053A5043324219 @default.
• W2895902053 hasAuthorship W2895902053A5051565200 @default.
• W2895902053 hasAuthorship W2895902053A5051945468 @default.
• W2895902053 hasAuthorship W2895902053A5054053950 @default.

• next